These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19302023)

  • 1. Therapeutic responses to exogenous VEGF-C administration in experimental lymphedema: immunohistochemical and molecular characterization.
    Jin DP; An A; Liu J; Nakamura K; Rockson SG
    Lymphat Res Biol; 2009; 7(1):47-57. PubMed ID: 19302023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An experimental model for the study of lymphedema and its response to therapeutic lymphangiogenesis.
    Cheung L; Han J; Beilhack A; Joshi S; Wilburn P; Dua A; An A; Rockson SG
    BioDrugs; 2006; 20(6):363-70. PubMed ID: 17176124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.
    Yoon YS; Murayama T; Gravereaux E; Tkebuchava T; Silver M; Curry C; Wecker A; Kirchmair R; Hu CS; Kearney M; Ashare A; Jackson DG; Kubo H; Isner JM; Losordo DW
    J Clin Invest; 2003 Mar; 111(5):717-25. PubMed ID: 12618526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody.
    Pytowski B; Goldman J; Persaud K; Wu Y; Witte L; Hicklin DJ; Skobe M; Boardman KC; Swartz MA
    J Natl Cancer Inst; 2005 Jan; 97(1):14-21. PubMed ID: 15632376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory manifestations of experimental lymphatic insufficiency.
    Tabibiazar R; Cheung L; Han J; Swanson J; Beilhack A; An A; Dadras SS; Rockson N; Joshi S; Wagner R; Rockson SG
    PLoS Med; 2006 Jul; 3(7):e254. PubMed ID: 16834456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic lymphangiogenesis with human recombinant VEGF-C.
    Szuba A; Skobe M; Karkkainen MJ; Shin WS; Beynet DP; Rockson NB; Dakhil N; Spilman S; Goris ML; Strauss HW; Quertermous T; Alitalo K; Rockson SG
    FASEB J; 2002 Dec; 16(14):1985-7. PubMed ID: 12397087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The resolution of lymphedema by interstitial flow in the mouse tail skin.
    Uzarski J; Drelles MB; Gibbs SE; Ongstad EL; Goral JC; McKeown KK; Raehl AM; Roberts MA; Pytowski B; Smith MR; Goldman J
    Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1326-34. PubMed ID: 18203849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.
    Visuri MT; Honkonen KM; Hartiala P; Tervala TV; Halonen PJ; Junkkari H; Knuutinen N; Ylä-Herttuala S; Alitalo KK; Saarikko AM
    Angiogenesis; 2015 Jul; 18(3):313-26. PubMed ID: 26018927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9.
    Rutkowski JM; Moya M; Johannes J; Goldman J; Swartz MA
    Microvasc Res; 2006 Nov; 72(3):161-71. PubMed ID: 16876204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
    Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
    Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal shock wave therapy combined with vascular endothelial growth factor-C hydrogel for lymphangiogenesis.
    Kim IG; Lee JY; Lee DS; Kwon JY; Hwang JH
    J Vasc Res; 2013; 50(2):124-33. PubMed ID: 23208012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study of gene therapy with human vascular endothelial growth factor-c in lymphedema].
    Zhou JG; Hu XQ; Cao WG; Li SL; Cheng KX; Liu NF; Zhang DS; Wu JJ; Yin LM; Liu DL
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2007 Nov; 23(6):519-21. PubMed ID: 18269031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental studies of VEGF-C gene for the treatment of chronic obstructive lymphedema in mouse tail model].
    Hu XQ; Jiang ZH; Liu NF
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2008 May; 24(3):207-11. PubMed ID: 18717357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth.
    Laakkonen P; Waltari M; Holopainen T; Takahashi T; Pytowski B; Steiner P; Hicklin D; Persaud K; Tonra JR; Witte L; Alitalo K
    Cancer Res; 2007 Jan; 67(2):593-9. PubMed ID: 17234768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts.
    Nykänen AI; Sandelin H; Krebs R; Keränen MA; Tuuminen R; Kärpänen T; Wu Y; Pytowski B; Koskinen PK; Ylä-Herttuala S; Alitalo K; Lemström KB
    Circulation; 2010 Mar; 121(12):1413-22. PubMed ID: 20231530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of an Acquired Lymphedema Model in the Mouse Hindlimb: Technical Refinement and Molecular Characteristics.
    Iwasaki D; Yamamoto Y; Murao N; Oyama A; Funayama E; Furukawa H
    Plast Reconstr Surg; 2017 Jan; 139(1):67e-78e. PubMed ID: 28027235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The VEGF-C/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function.
    Hagura A; Asai J; Maruyama K; Takenaka H; Kinoshita S; Katoh N
    J Dermatol Sci; 2014 Feb; 73(2):135-41. PubMed ID: 24252749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the molecular pathogenesis and targeted treatment of lymphedema.
    Saaristo A; Karkkainen MJ; Alitalo K
    Ann N Y Acad Sci; 2002 Dec; 979():94-110. PubMed ID: 12543720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory and lymphangiogenetic effects of low-level laser therapy on lymphedema in an experimental mouse tail model.
    Jang DH; Song DH; Chang EJ; Jeon JY
    Lasers Med Sci; 2016 Feb; 31(2):289-96. PubMed ID: 26714983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Important Role of VEGF-C in Promoting Lymphedema Development.
    Gousopoulos E; Proulx ST; Bachmann SB; Dieterich LC; Scholl J; Karaman S; Bianchi R; Detmar M
    J Invest Dermatol; 2017 Sep; 137(9):1995-2004. PubMed ID: 28526302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.